ProQR Therapeutics N.V. (PRQR)
NASDAQ: PRQR · Real-Time Price · USD
1.975
-0.045 (-2.23%)
Aug 14, 2025, 11:39 AM - Market open
ProQR Therapeutics Employees
ProQR Therapeutics had 166 employees as of December 31, 2024. The number of employees increased by 10 or 6.07% compared to the previous year.
Employees
166
Change (1Y)
10
Growth (1Y)
6.07%
Revenue / Employee
$121,187
Profits / Employee
-$280,491
Market Cap
208.05M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 166 | 10 | 6.07% |
Dec 31, 2023 | 157 | 26 | 20.28% |
Dec 31, 2022 | 130 | -51 | -28.30% |
Dec 31, 2021 | 182 | 31 | 20.74% |
Dec 31, 2020 | 150 | -4 | -2.59% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
PRQR News
- 7 days ago - ProQR Announces Second Quarter 2025 Operating and Financial Results - GlobeNewsWire
- 17 days ago - ProQR Announces Upcoming Presentation at RNA Editing Summit - GlobeNewsWire
- 6 weeks ago - ProQR Announces CTA Submission for Phase 1 Study of AX-0810 Targeting NTCP - GlobeNewsWire
- 3 months ago - ProQR Announces Upcoming Scientific Presentations at ASGCT and TIDES Conferences - GlobeNewsWire
- 3 months ago - ProQR Announces First Quarter 2025 Operating and Financial Results - GlobeNewsWire
- 3 months ago - ProQR Announces Webcast of Presentation at the 2025 Citizens Life Sciences Conference - GlobeNewsWire
- 3 months ago - ProQR Announces Annual General Meeting of Shareholders to be Held June 3, 2025 - GlobeNewsWire
- 4 months ago - ProQR Strengthens Leadership with Appointments of CFO and CMO to Support Next Phase of Growth - GlobeNewsWire